Acute antipsychotic-induced akathisia revisited

British Journal of Psychiatry

Volumn 196, Issue 2, 2010, Pages 89-91

  Poyurovsky, Michael ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Technion Medical School   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMISULPRIDE; ARIPIPRAZOLE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIPERIDEN; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLONIDINE; CLOZAPINE; CYPROHEPTADINE; DIAZEPAM; LORAZEPAM; MIANSERIN; MIRTAZAPINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PLACEBO; PROPRANOLOL; QUETIAPINE; RISPERIDONE; SEROTONIN 2A ANTAGONIST; TRIHEXYPHENIDYL; ZIPRASIDONE;

AGRANULOCYTOSIS; AKATHISIA; ANXIETY DISORDER; BRADYCARDIA; CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSTONIA; EVIDENCE BASED PRACTICE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MOOD DISORDER; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PRACTICE GUIDELINE; REVIEW; RISK; RISK REDUCTION; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SYMPTOM; TARDIVE DYSKINESIA; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN;

ACUTE DISEASE; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; HUMANS; MIANSERIN; PRACTICE GUIDELINES AS TOPIC; RECEPTORS, SEROTONIN, 5-HT2;

EID: 76749149554     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.070540     Document Type: Review

References (14)

1. Kane JM, Fleischhacker WW, Hansen L, Perlis R, Pikalov A, Assunçāo-Talbott S. Akathisia: an updated review focusing on second-generation antipsychotics. J Clin Psychiatry 2009; 70: 627-43.
2. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209-23.
3. Miller DD, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, et al. Extrapyramidal side-effects of antipsychotics in a randomised trial. Br J Psychiatry 2008; 193: 279-88.
4. Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2008; 371: 1085-97.
5. Sikich L, Frazier JA, McClellan J, Findling RL, vitiello B, Ritz L, et al. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry 2008; 165: 1420-31.
6. Gao K, Kemp DE, Ganocy SJ, Gajwani P, Xia G, Calabrese JR. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol 2008; 28: 203-9.
7. Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. Biol Psychiatry 2006; 59: 1071-7.
8. Baskak B, Atbasoglu EC, Ozguven HD, Saka MC, Gogus AK. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol. 2007; 27: 289-94.
9. Barnes TRE, McPhillips MA. Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. Br J Psychiatry 1999; 174 (suppl 38): 34-43.
10. Poyurovsky M, Weizman A. Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem. Br J Psychiatry 2001; 179: 4-8.
11. Poyurovsky M, Weizman R, Weizman A. Aripiprazole's receptor pharmacology and extrapyramidal side effects. Am J Psychiatry 2008; 165: 398.
12. 2A inverse agonist with potential for treating various neuropsychiatrie disorders. Expert Opin Pharmacother 2008; 9: 3251-9.
13. Avital A, Gross-lsseroff R, Stryjer R, Hermesh H, Weizman A, Shiloh R. Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study. Eur Neuropsychopharmacol 2009; 19: 476-82.
14. varty GB, Hodgson RA, Pond AJ, Grzelak ME, Parker EM, Hunter JC. The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates. Psychopharmacology (Berl) 2008; 200: 393-401.